acecainide has been researched along with Heart Diseases in 1 studies
Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In six normal subjects and 6 patients with primary cardiomyopathy, left ventricular performance was evaluated at rest and during isometric handgrip exercise after 4 days of oral N-acetylprocainamide (NAPA) at each of the three dosage levels (3, 4, 5, and 6 gm/day)." | 1.26 | Hemodynamic effects of N-acetylprocainamide in heart disease. ( Amon, KW; Crawford, MH; Kennedy, GT; Ludden, TM; O'Rourke, RA; Sodums, MT, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawford, MH | 1 |
| Ludden, TM | 1 |
| Kennedy, GT | 1 |
| Sodums, MT | 1 |
| O'Rourke, RA | 1 |
| Amon, KW | 1 |
1 other study available for acecainide and Heart Diseases
| Article | Year |
|---|---|
Hemodynamic effects of N-acetylprocainamide in heart disease.
Topics: Acecainide; Administration, Oral; Blood Pressure; Female; Heart Diseases; Heart Rate; Hemodynamics; | 1982 |